S&P/ASX 200 Index (ASX: XJO) shares are up 0.27% to 9,086.2 points as earnings season continues on Monday.
Among the 11 market sectors, materials and miners are in the lead today, up 1.7%.
The sector pushed higher amid BHP Group Ltd (ASX: BHP) shares reaching a new record of $67.72, up 3.9%, in early trading.
The financials sector is the laggard today, down 1%.
Let's check out some new expert ratings on three ASX 200 sector heavyweights.
Image source: Getty Images
Pro Medicus Ltd (ASX: PME)
The Pro Medicus share price is $191.56, down 0.02% today and down 37% over 12 months.
Pro Medicus shares jumped 7.1% last week after the company released its FY26 results.
The Pro Medicus share price is up 20% since the downtrodden healthcare sector pivoted on 3 June.
Morgans maintained its accumulate rating on Pro Medicus shares after the report.
Analyst Iain Wilkie said:
FY26 confirms PME is executing at an even higher level than the market gave it credit for. EBIT margin of 74.9% and constant currency EBIT growth of 30.6% both beat expectations comfortably, with the FX-driven softness in headline revenue a currency story, not a demand or execution one.
Momentum remains broad-based, implementations are ahead of schedule, renewals are a clean sweep, and the pipeline is opening up in new segments rather than just deepening in existing ones.
Looking ahead, FY27 is shaping as a genuine standout year. With four Trinity cohorts and 15 other implementations already banked rather than still ramping, the P&L gets the full run-rate benefit without needing fresh signings just to stand still.
Nothing in the result gives us any pause for change versus our positive view.
Fortescue Ltd (ASX: FMG)
The Fortescue share price is $18.08, up 1.8% today and down 10% over 12 months.
Morgans has a hold rating on this ASX 200 mining share following the company's FY26 report last week.
Analyst Adrian Prendergast said:
A mixed FY26 result from FMG, with higher revenue helping to offset cost increases and elevated admin/R&D to help keep underlying earnings flat.
With the focus on FY27 guidance, Iron Bridge remained a key issue, with the magnetite operation struggling through ramp up and with elevated costs.
Plans for a green steel plant was big news, although difficult to quantify.
Commonwealth Bank of Australia (ASX: CBA)
The CBA share price is $155.24, down 1.7% today and down 9% over 12 months.
CBA reported a 7% increase in its cash net profit after tax (NPAT) to $11 billion for FY26.
John Athanasiou from Red Leaf Securities has a sell rating on this ASX 200 bank share.
He explained (courtesy The Bull):
CBA shares deserves to trade at a premium given its dominant retail franchise, strong technology platform, solid deposit base and consistent execution.
However, Australian banking remains a mature industry, with intense competition across mortgages and deposits limiting the potential for outsized earnings growth.
At a premium valuation, investors are paying a higher price for quality, leaving little room for disappointment.
After a substantial re-rating, investors may be better served taking some profits and reallocating capital towards businesses offering stronger growth at more reasonable valuations.
